title: Report of an additional case of anti-tumor necrosis factor therapy and Listeria monocytogenes infection: comment on the letter by Glück et al.
authors.forename: Angel Garcia
authors.initials: AG
authors.lastname: Aparicio
authors.forename: Santiago
authors.initials: S
authors.lastname: Muñoz-Fernández
authors.forename: Gema
authors.initials: G
authors.lastname: Bonilla
authors.forename: Ambrosio
authors.initials: A
authors.lastname: Miralles
authors.forename: Victor
authors.initials: V
authors.lastname: Cerdeño
authors.forename: Emilio
authors.initials: E
authors.lastname: Martín-Mola
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000276:immunology*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000276:immunology; D015535:Arthritis, Psoriatic / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000276:immunology; D007213:Indomethacin / Q000627:therapeutic use; D000069285:Infliximab; D008089:Listeria monocytogenes / Q000302:isolation & purification* / Q000472:pathogenicity; D008088:Listeriosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D011239:Prednisolone; D000069285:Infliximab; D007213:Indomethacin